Key details
Phase
Early testing / Safety & dosing
Sponsor
Universitas Padjadjaran
Enrollment target
~60 participants
Primary completion
February 2025
This trial's estimated completion date has passed — the record may not be fully up to date.
Age range
18 Years – 59 Years
Last updated January 2025